Xylem (NYSE:XYL) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Key Points

• Stifel Nicolaus has increased its price target for Xylem from $162.00 to $175.00, indicating a potential upside of 23.40% from the current stock price and maintaining a "buy" rating.
• Xylem recently reported quarterly earnings of $1.26 per share, surpassing estimates of $1.15, alongside a revenue increase of 6.1% year-over-year to $2.30 billion.
• Analyst ratings for Xylem show a consensus of "Moderate Buy," with three analysts rating it as hold and six as buy, while the average price target remains at $151.14.

Xylem (NYSE:XYL - Get Free Report) had its price objective boosted by analysts at Stifel Nicolaus from $162.00 to $175.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a "buy" rating on the industrial products company's stock. Stifel Nicolaus' target price would suggest a potential upside of 23.40% from the company's current price.

A number of other brokerages have also issued reports on XYL. Robert W. Baird lowered their target price on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a research note on Wednesday, April 30th. Citigroup reiterated a "buy" rating and issued a $152.00 price target (up previously from $137.00) on shares of Xylem in a report on Monday, July 14th. Royal Bank Of Canada raised their price objective on Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a report on Wednesday, April 30th. JPMorgan Chase & Co. initiated coverage on Xylem in a research report on Friday, May 30th. They set an "overweight" rating and a $148.00 target price for the company. Finally, Raymond James Financial raised Xylem to a "hold" rating in a research report on Thursday, May 15th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Xylem has a consensus rating of "Moderate Buy" and a consensus price target of $151.14.

Xylem Trading Down 1.9%

NYSE XYL traded down $2.81 on Friday, hitting $141.81. 704,444 shares of the stock were exchanged, compared to its average volume of 1,499,332. Xylem has a 52-week low of $100.47 and a 52-week high of $144.83. The firm has a market capitalization of $34.51 billion, a P/E ratio of 38.09, a P/E/G ratio of 2.37 and a beta of 1.12. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.41 and a current ratio of 1.89. The stock has a fifty day moving average price of $129.08 and a two-hundred day moving average price of $124.10.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.54% and a return on equity of 10.12%. The firm had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.20 billion. During the same period in the previous year, the company earned $1.09 EPS. The firm's revenue for the quarter was up 6.1% compared to the same quarter last year. Research analysts forecast that Xylem will post 4.65 EPS for the current fiscal year.

Hedge Funds Weigh In On Xylem

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Orion Portfolio Solutions LLC grew its stake in Xylem by 56.7% during the 4th quarter. Orion Portfolio Solutions LLC now owns 7,656 shares of the industrial products company's stock valued at $888,000 after purchasing an additional 2,770 shares during the last quarter. Schroder Investment Management Group boosted its position in Xylem by 0.9% in the fourth quarter. Schroder Investment Management Group now owns 28,661 shares of the industrial products company's stock valued at $3,333,000 after buying an additional 259 shares during the last quarter. Geode Capital Management LLC increased its holdings in Xylem by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock worth $671,623,000 after buying an additional 135,492 shares during the period. Broderick Brian C raised its position in Xylem by 4.6% during the 4th quarter. Broderick Brian C now owns 74,636 shares of the industrial products company's stock worth $8,659,000 after buying an additional 3,286 shares during the last quarter. Finally, Resona Asset Management Co. Ltd. acquired a new stake in Xylem during the 4th quarter valued at approximately $9,440,000. Hedge funds and other institutional investors own 87.96% of the company's stock.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.